293 related articles for article (PubMed ID: 19471117)
1. Rapamycin decelerates cellular senescence.
Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
Blagosklonny MV
Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
[TBL] [Abstract][Full Text] [Related]
3. mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging.
Wesierska-Gadek J
Aging (Albany NY); 2010 Dec; 2(12):892-3. PubMed ID: 21149896
[No Abstract] [Full Text] [Related]
4. Rapamycin retards epigenetic ageing of keratinocytes independently of its effects on replicative senescence, proliferation and differentiation.
Horvath S; Lu AT; Cohen H; Raj K
Aging (Albany NY); 2019 May; 11(10):3238-3249. PubMed ID: 31136303
[TBL] [Abstract][Full Text] [Related]
5. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
[TBL] [Abstract][Full Text] [Related]
6. Geroconversion: irreversible step to cellular senescence.
Blagosklonny MV
Cell Cycle; 2014; 13(23):3628-35. PubMed ID: 25483060
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2013 Sep; 12(18):3063-9. PubMed ID: 23974099
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria are required for pro-ageing features of the senescent phenotype.
Correia-Melo C; Marques FD; Anderson R; Hewitt G; Hewitt R; Cole J; Carroll BM; Miwa S; Birch J; Merz A; Rushton MD; Charles M; Jurk D; Tait SW; Czapiewski R; Greaves L; Nelson G; Bohlooly-Y M; Rodriguez-Cuenca S; Vidal-Puig A; Mann D; Saretzki G; Quarato G; Green DR; Adams PD; von Zglinicki T; Korolchuk VI; Passos JF
EMBO J; 2016 Apr; 35(7):724-42. PubMed ID: 26848154
[TBL] [Abstract][Full Text] [Related]
9. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina LG; Leontieva OV; Bukreeva EI; Demidenko ZN; Gudkov AV; Blagosklonny MV
Aging (Albany NY); 2010 Jun; 2(6):344-52. PubMed ID: 20606252
[TBL] [Abstract][Full Text] [Related]
10. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.
Rodier F; Coppé JP; Patil CK; Hoeijmakers WA; Muñoz DP; Raza SR; Freund A; Campeau E; Davalos AR; Campisi J
Nat Cell Biol; 2009 Aug; 11(8):973-9. PubMed ID: 19597488
[TBL] [Abstract][Full Text] [Related]
11. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
12. Senescence regulation by mTOR.
Dulic V
Methods Mol Biol; 2013; 965():15-35. PubMed ID: 23296649
[TBL] [Abstract][Full Text] [Related]
13. Aging, cellular senescence, and cancer.
Campisi J
Annu Rev Physiol; 2013; 75():685-705. PubMed ID: 23140366
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.
Kolesnichenko M; Hong L; Liao R; Vogt PK; Sun P
Cell Cycle; 2012 Jun; 11(12):2391-401. PubMed ID: 22627671
[TBL] [Abstract][Full Text] [Related]
15. Feedback between p21 and reactive oxygen production is necessary for cell senescence.
Passos JF; Nelson G; Wang C; Richter T; Simillion C; Proctor CJ; Miwa S; Olijslagers S; Hallinan J; Wipat A; Saretzki G; Rudolph KL; Kirkwood TB; von Zglinicki T
Mol Syst Biol; 2010; 6():347. PubMed ID: 20160708
[TBL] [Abstract][Full Text] [Related]
16. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.
Orjalo AV; Bhaumik D; Gengler BK; Scott GK; Campisi J
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17031-6. PubMed ID: 19805069
[TBL] [Abstract][Full Text] [Related]
17. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
[TBL] [Abstract][Full Text] [Related]
18. S6K in geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Cycle; 2013 Oct; 12(20):3249-52. PubMed ID: 24036549
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
Piegari E; De Angelis A; Cappetta D; Russo R; Esposito G; Costantino S; Graiani G; Frati C; Prezioso L; Berrino L; Urbanek K; Quaini F; Rossi F
Basic Res Cardiol; 2013 Mar; 108(2):334. PubMed ID: 23411815
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia, MTOR and autophagy: converging on senescence or quiescence.
Blagosklonny MV
Autophagy; 2013 Feb; 9(2):260-2. PubMed ID: 23192222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
